Unknown

Dataset Information

0

Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.

ABSTRACT: At present, inhibitors of ?/?-hydrolase domain?6 (ABHD6) are viewed as a promising approach to treat inflammation and metabolic disorders. This article describes the development of 1,2,5-thiadiazole carbamates as ABHD6 inhibitors. Altogether, 34 compounds were synthesized, and their inhibitory activity was tested using lysates of HEK293 cells transiently expressing human ABHD6 (hABHD6). Among the compound series, 4-morpholino-1,2,5-thiadiazol-3-yl cyclooctyl(methyl)carbamate (JZP-430) potently and irreversibly inhibited hABHD6 (IC50 =44 nM) and showed ?230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL), the main off-targets of related compounds. Additionally, activity-based protein profiling indicated that JZP-430 displays good selectivity among the serine hydrolases of the mouse brain membrane proteome. JZP-430 has been identified as a highly selective, irreversible inhibitor of hABHD6, which may provide a novel approach in the treatment of obesity and type?II diabetes.

SUBMITTER: Patel JZ 

PROVIDER: S-EPMC4471478 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

At present, inhibitors of α/β-hydrolase domain 6 (ABHD6) are viewed as a promising approach to treat inflammation and metabolic disorders. This article describes the development of 1,2,5-thiadiazole carbamates as ABHD6 inhibitors. Altogether, 34 compounds were synthesized, and their inhibitory activity was tested using lysates of HEK293 cells transiently expressing human ABHD6 (hABHD6). Among the compound series, 4-morpholino-1,2,5-thiadiazol-3-yl cyclooctyl(methyl)carbamate (JZP-430) potently a  ...[more]

Similar Datasets

Unknown Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics.
| S-EPMC2912405 | biostudies-literature
Unknown Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of ?/?-hydrolase domain containing 6 (ABHD6).
| S-EPMC3987869 | biostudies-literature
Unknown Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.
| S-EPMC3778430 | biostudies-literature
Unknown O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.
| S-EPMC3382460 | biostudies-other
Unknown Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE.
| S-EPMC8430704 | biostudies-literature
Unknown Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors.
| S-EPMC8533211 | biostudies-literature
Unknown First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive Decline.
| S-EPMC10641827 | biostudies-literature
Unknown Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors.
| S-EPMC4834658 | biostudies-literature
Unknown Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile.
| S-EPMC10142904 | biostudies-literature
Unknown Discovery of Potent and Selective Antibody-Drug Conjugates with Eg5 Inhibitors through Linker and Payload Optimization.
| S-EPMC6912867 | biostudies-literature